Trademark dispute – Katy Perry vs Katie Perry
Katy is a hugely successful American pop star. Her fame carried her to extraterrestrial heights and even extended briefly into outer space for an unforgettable 10 minutes and 21 seconds. Beyond her music career, she has established a suite of companies to safeguard her various commercial ventures. Killer Queen, LLC serves as the vehicle through which she protects and manages her intellectual property rights.
Dormant litigation dismissal – when does delay become prejudicial?
In a recent Johannesburg High Court judgment, the plaintiff, Karanie, instituted an action against the life insurer, the defendant, in December 2012. The claim sought payment of benefits allegedly due under a life insurance policy. The defendant defended the action and filed a counterclaim to recover payments already made under the policy.
The replica dispute – when a house becomes a lawsuit
When a private home becomes the centrepiece of a Bad Bunny production, the legal foundations may be just as important as the concrete ones. Eighty-four-year-old Puerto Rican homeowner Román Carrasco Delgado ("Carrasco"), who says he designed and built his distinctive salmon-coloured home with his brother, filed a lawsuit in Puerto Rico's Superior Court in September 2025 against several defendants, including Bad Bunny.
BNPL credit scoring – could good borrowers be penalised?
South Africa should carefully assess how short-term instalment products are interpreted before Buy Now, Pay Later (BNPL) data shapes access to mainstream credit. The country could risk turning BNPL into a product that shuts people out of mainstream credit rather than helping them into it. This could happen if BNPL data enters credit-scoring systems that were never designed to interpret this type of product fairly.
Workplace injury claims – when does employment really end?
The Compensation for Occupational Injuries and Diseases Act (COIDA) requires the state’s Compensation Commissioner to compensate employees for losses resulting from workplace injuries. This applies when an injury complies with the legal definition. Some employers also acquire workplace injury cover from private insurance companies. However, these companies sometimes reject claims and create unnecessary workplace slip-ups for employees seeking compensation.
Digital interface branding – the new brand battleground
Digital business is the new frontier of modern entrepreneurship, and applications (apps) have become the gateway to almost every service imaginable. In a global economy driven by interconnectivity and advancing technology, start-up companies in all digital industries, particularly in FinTech, are quickly becoming the Oil and Rail industry equivalent of the 21st century.
The force of JBCC substitution – no second bite at arbitration
Construction adjudication often receives treatment as interim. Arbitration or litigation then waits as the final forum. In a judgment delivered by the Eastern Cape Division in Makhanda on 30 April 2026, Krüger AJ issued a clear warning. He stressed that this assumption only holds if the contract supports it.
The chosen executor – a title of trust and a test...
Death has no diary. It does not wait for neat files, updated passwords, or family harmony. It arrives when it arrives. And when it does, the executor steps in. In theory, it is a straightforward appointment. In practice, it is anything but. I have seen firsthand how often people underestimate this role. Appointing an executor is not a box-ticking exercise. It is one of the most important decisions in an estate plan. Yet it remains one of the least interrogated.
Professional indemnity ruling – the cost of late notification
The Plaintiffs operated restaurant businesses and appointed the defendant as their insurance broker. The defendant's mandate required it to procure commercial insurance on the Plaintiffs' behalf. On 4 June 2019, the defendant obtained policies from Renasa Insurance Company Ltd. However, these policies did not include an extended business interruption clause covering losses arising from infectious disease outbreaks.
Patenting genetic innovation – lessons from REGENXBIO v Sarepta
As gene therapy technologies continue to reshape modern medicine, patent law increasingly faces a difficult task. Courts must distinguish products of nature from genuine biological engineering. They frequently decide whether inventions involving genetic material represent technological innovation or merely identify naturally occurring biological features.




































